Cerevance vs Saluda Medical
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cerevance is a CNS drug discovery company using proprietary NETSseq single-nucleus transcriptomics to identify cell-type-specific drug targets in human brain tissue; lead program CVN424 for Parkinson's disease completed Phase 2;
About
Cerevance is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in Cambridge, Massachusetts, focused on developing novel therapeutics for central nervous system (CNS) diseases. The company's core technological advantage is its NETSseq (Nuclear Enrichment for Transcriptome Sequencing) platform, which profiles gene expression at the individual cell-type level in post-mortem human brain tissue. By identifying transcriptional and epigenetic differences between specific cell types — such as dopaminergic neurons versus medium spiny neurons — Cerevance can discover drug targets that are active in disease-relevant cell populations and largely silent in others, enabling greater target selectivity and potentially better tolerability than broad CNS agents.
Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS system with real-time neural feedback; raised $100M in Jan 2025; received FDA clearance for automated EVA programming platform.
About
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US operations in Marlborough, Massachusetts), Saluda''s flagship product is the Evoke Spinal Cord Stimulation (SCS) System — the world''s first SCS system that senses and measures neural responses to stimulation (evoked compound action potentials, or ECAPs) and automatically adjusts therapy in real time based on each patient''s neurophysiological feedback. This closed-loop approach provides more precise, consistent pain relief compared to conventional open-loop SCS systems.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.